🔥 Monday 30 March 2026 Mon, 30 Mar 2026

Advanced Innergy Holdings has tabled a non-binding proposal to acquire Matrix Composites & Engineering at a substantial premium, aiming to cement its foothold in the Asia-Pacific subsea sector.

Stavely Minerals has issued an amended 2026 Mineral Resource Estimate and Scoping Study, correcting key data omissions and confirming significant growth in its copper, gold, and silver resources. The updated study highlights promising open pit and underground mining potential in Western Victoria.

Fiducian Investment Management Services Limited has reached a heads of agreement with ASIC to resolve civil proceedings over misleading disclosures in its Diversified Social Aspirations Fund. The settlement includes a $7.3 million penalty and legal costs, pending court approval.

Auric Mining Limited reported a near doubling of net profit to $5.2 million for 2025, marking its successful transition to a gold producer with key operational milestones at Munda and the acquisition of Burbanks processing facility.

WA Kaolin Limited has announced a partially underwritten pro-rata rights offer to raise up to $34.9 million, aiming to reduce debt and provide working capital to stabilise its Wickepin kaolin operations amid ongoing ASX suspension.

Cobre Limited has completed a $60 million capital raise to acquire majority ownership of the Sierra Atacama Copper Mine in Chile, marking its transition from explorer to producer. Meanwhile, substantial shareholder Sinomine has increased its investment in Cobre’s Botswana copper project.

Sierra Nevada Gold has established a wholly owned Saudi subsidiary, Arabian American Minerals LLC, to spearhead exploration at the As Safra copper-gold project, aligning with Saudi Arabia’s Vision 2030 and preparing for imminent drilling.

Lode Resources has identified a new high-grade silver and antimony prospect, Blocks East, within its Greater Montezuma Project in Tasmania, expanding its strategic foothold in a prolific mining region.

Xenitra Limited has secured a $30 million AUD sales agreement for Danone products with Rockcheck Group and established its Australian subsidiary as an authorised supplier, marking a major step in its China market strategy.

Alterity Therapeutics has secured encouraging regulatory feedback from the FDA on its ATH434 Phase 3 program for Multiple System Atrophy, marking a critical step towards pivotal trial initiation.

Blue Star Helium has successfully raised A$10 million through an oversubscribed placement, positioning itself to accelerate production at its Galactica and Pegasus helium projects.

Aeris Resources has expanded its Golden Plateau drilling program to 14,000 metres following a series of strong high-grade gold intersections, reinforcing the deposit’s potential as a key ore source for its Cracow operation.

Aldoro Resources has reported a significant 50% increase in rare earth and strontium grades across a 525-meter continuous mineralised interval at its Kameelburg deposit in Namibia, reinforcing the project's scale and potential.

Botala Energy has commenced drilling its first commercial production well at the Serowe CBM Project in Botswana, marking a pivotal step toward large-scale gas production and regional energy supply.

Accelerate Resources is set to drill the Fluffy Prospect at its Balagundi Project in Western Australia, targeting significant gold mineralisation after three decades of dormancy. Historic and recent surveys have sharpened focus on this promising site.

Buxton Resources has agreed to sell its 49% stake in the Copper Wolf joint venture to IGO for approximately A$6.15 million, while retaining full ownership of surrounding tenements and regaining strategic freedom in Arizona.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.

Aroa Biosurgery has completed its Symphony randomised controlled trial, demonstrating improved healing rates for diabetic foot ulcers compared to standard care. The preliminary results pave the way for clinical adoption and potential US reimbursement.

RocketBoots has secured a significant A$3.3 million activation contract with a leading multinational retailer, marking the start of a global deployment phase that complements its existing SaaS agreement and promises near-term revenue growth.

Cynata Therapeutics has completed the 100-day primary evaluation period for its Phase 2 trial of CYP-001 in acute graft versus host disease, with results expected in June 2026. This milestone marks a critical step for the biotech’s lead cell therapy candidate in a condition with few effective treatments.

EML Payments has appointed Adam Olding as its Global CEO, marking a pivotal step in its EML 2.0 transformation and signalling strengthened leadership to drive growth. Concurrently, regulatory developments around its Australian banking licence application introduce new compliance dynamics.

Algorae Pharmaceuticals has launched a second collaboration with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its drug development pipeline.

West Cobar Metals reports promising metallurgical testwork supporting a low-cost heap leach processing pathway at its Salazar Critical Minerals Project, highlighting strong recoveries of high-value rare earths including dysprosium and terbium.

Rimfire Pacific Mining has exercised its option to acquire 100% of the Rabbit Trap Scandium Project, consolidating its position in a promising scandium resource in central NSW. Recent drilling results underpin the acquisition, highlighting significant mineralisation and growth potential.